Free public records show Novitium Pharma in 30 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
103 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
6 recalls since 2015 (6 for medicines)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Markets we cover where free public records show Novitium Pharma: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Novitium Pharma is in.
Stories on the topics Novitium Pharma works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read